464490 (464490)

Overview

QuadMedicine, Inc. is a pioneering company engaged in the research, development, and manufacturing of healthcare vaccination needles utilizing the innovative microneedle array patch (MAP) technology. Established in 2016 and based in Seongnam-si, South Korea, QuadMedicine is dedicated to creating effective vaccination solutions aimed at children living in remote areas. These vaccinations are designed to defend against common yet serious infectious diseases, including diphtheria, tetanus, polio, measles, and hepatitis B. The company places a strong emphasis on integrating advanced technology in the realms of medical and pharmaceutical microneedle development, facilitating easy access to essential healthcare for vulnerable populations.

Products and Services

• Microneedle Array Patch (MAP) Vaccination Needles

  QuadMedicine specializes in developing MAP vaccination needles, which are designed to deliver vaccines painlessly and effectively through the skin using a series of micro-sized needles. This innovative approach not only reduces pain typically associated with traditional injections but also improves the vaccine uptake rate among children, especially in remote settings.

• Vaccination Development for Infectious Diseases

  The company focuses on creating vaccines specifically tailored to combat infectious diseases such as diphtheria, tetanus, polio, measles, and hepatitis B. Their research aims to enhance the protective immunization of children in underserved regions where healthcare access is limited.

• Technology Integration for Microneedle Development

  QuadMedicine is committed to integrating cutting-edge technologies into microneedle production processes. This focus helps streamline the development cycle of medical devices and pharmaceuticals, ensuring the production of high-quality microneedles that meet clinical standards.

• Fundamental Research and Prototyping

  The company provides vital foundational research in the field of microneedles, including prototyping and clinical trials. Their rigorous prototyping phase allows for the adjustment and optimization of MAP designs before entering comprehensive clinical testing.

• Clinical Trial Support

  QuadMedicine plays an integral role in supporting clinical trials for their MAP products. By partnering with research institutions and healthcare professionals, the company ensures the efficacy and safety of their products through extensive testing and evaluation.